IMUNON stock rallies 19% on early results for COVID-19 vaccine [Seeking Alpha]
Imunon, Inc. (IMNN)
Company Research
Source: Seeking Alpha
The lab, Wistar Institute, conducted the challenge against the SARS-CoV-2 variant XBB.1.5, which health officials consider a variant of concern. The study utilized a clinical vector that IMUNON plans to bring into its Phase 1 study in Q2, according to the company IMUNON said an ongoing study has shown that the IMMN-101-induced immune response was maintained for up to four months after vaccination. The vaccine candidate utilizes IMUNON's PlaCCine technology, which the company has been developing as an alternative to mRNA vaccines. MRNA vaccines currently dominate the U.S. COVID-19 market. Both Pfizer ( PFE )/BioNTech ( BNTX ) and Moderna's ( MRNA ) COVID-19 vaccines are mRNA vaccines. A third vaccine, made by Novavax ( NVAX ), is classified as a protein subunit vaccine. Recommended For You Recommended For You About IMNN Stock Related Stocks Trending Analysis Trending News
Show less
Read more
Impact Snapshot
Event Time:
IMNN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
IMNN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
IMNN alerts
High impacting Imunon, Inc. news events
Weekly update
A roundup of the hottest topics
IMNN
News
- IMUNON's IND Application Cleared to Begin Human Testing of IMNN-101 [Yahoo! Finance]Yahoo! Finance
- IMUNON’s IND Application Cleared to Begin Human Testing of IMNN-101GlobeNewswire
- IMNN: IND Application Submitted for Phase 1/2 Trial of Seasonal COVID-19 Vaccine… [Yahoo! Finance]Yahoo! Finance
- IMUNON Reports Compliance with Nasdaq Listing Requirements [Yahoo! Finance]Yahoo! Finance
- IMUNON Reports Compliance with Nasdaq Listing RequirementsGlobeNewswire
IMNN
Analyst Actions
- 3/18/24 - HC Wainwright
IMNN
Sec Filings
- 4/29/24 - Form ARS
- 4/26/24 - Form DEF
- 4/11/24 - Form 8-K
- IMNN's page on the SEC website